{
  "id": 36,
  "text": "After the selection and critical appraisal of the articles, a summary of the scientific evidence was developed.# 3.3 Formulation of guidelines The development group developed guidelines for staging, FST, management (stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy, LACC, primary distant metastatic disease, CCIP, and recurrent disease), and follow-up for patients with cervical cancer.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: After the selection and critical appraisal of the articles, a summary of the scientific evidence was developed.# 3.3 Formulation of guidelines The development group developed guidelines for staging, FST, management (stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy, LACC, primary distant metastatic disease, CCIP, and recurrent disease), and follow-up for p\n\n<question>: ",
  "ChatGPT_response_0": "在制定指南时，团队通常会经过选择和评估文章的过程，然后总结科学证据。发展小组会制定关于分期、FST、管理和随访的指南，针对宫颈癌患者的不同情况制定具体指导，例如早期宫颈癌（T1a、T1b1/T2a1）、简单子宫切除术后诊断出的临床隐匿性宫颈癌、局部晚期宫颈癌（LACC）、原发性远处转移性疾病、在适用情况下的子宫颈癌介入治疗方案（CCIP）、以及复发疾病情况的管理等。这些指南的制定有助于规范宫颈癌患者的诊断、治疗和随访过程，以提高他们的治疗效果和生存率。",
  "query": "在制定指南时，团队是如何确保考虑到分期、FST、管理和随访的？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在制定指南时，团队是如何确保考虑到分期、FST、管理和随访的？\n\n<reference text>: After the selection and critical appraisal of the articles, a summary of the scientific evidence was developed.# 3.3 Formulation of guidelines The development group developed guidelines for staging, FST, management (stage T1a, T1b1/T2a1, clinically occult cervical cancer diagnosed after simple hysterectomy, LACC, primary distant metastatic disease, CCIP, and recurrent disease), and follow-up for patients with cervical cancer.\n\n<reply>: ",
  "response": "在制定指南时，团队通常会经过选择和评估文章的过程，然后总结科学证据。发展小组会制定关于分期、FST、管理和随访的指南，针对宫颈癌患者的不同情况制定具体指导，例如早期宫颈癌（T1a、T1b1/T2a1）、简单子宫切除术后诊断出的临床隐匿性宫颈癌、局部晚期宫颈癌（LACC）、原发性远处转移性疾病、在适用情况下的子宫颈癌介入治疗方案（CCIP）、以及复发疾病情况的管理等。这些指南的制定有助于规范宫颈癌患者的诊断、治疗和随访过程，以提高他们的治疗效果和生存率。"
}